Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities

Biochemical Pharmacology

Volumn 65, Issue 11, 2003, Pages 1843-1852

  Morita, Naomi ^a   Yasumori, Toshio ^a   Nakayama, Kazuo ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Efflux; MDR1; P Glycoprotein; Polymorphism; SNP; Transporter

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; DIGOXIN; MULTIDRUG RESISTANCE PROTEIN 1; RECOMBINANT PROTEIN; RECOMBINASE; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE LOCATION; GENOME; HAPLOTYPE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 0038323843     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00178-3     Document Type: Article

References (41)

1. Evans W.E., Johnson J.A. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2:2001;9-39.
2. Lee C.R., Goldstein J.A., Pieper J.A. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics. 12:2002;251-263.
3. Ayrton A., Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 31:2001;469-497.
4. Wada M., Toh S., Taniguchi K., Nakamura T., Uchiumi T., Kohno K., Yoshida I., Kimura A., Sakisaka S., Adachi Y., Kuwano M. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum. Mol. Genet. 7:1998;203-207.
5. Horio M., Gottesman M.M., Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. U.S.A. 85:1988;3580-3584.
6. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7735-7738.
7. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86:1989;695-698.
8. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
9. Yamazaki M., Neway W.E., Ohe T., Chen I., Rowe J.F., Hochman J.H., Chiba M., Lin J.H. In vitro substrate identification studies for P-glycoprotein-mediated transport: species difference and predictability of in vivo results. J. Pharmacol. Exp. Ther. 296:2001;723-735.
10. Yamaguchi H., Yano I., Saito H., Inui K. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. J. Pharmacol. Exp. Ther. 300:2002;1063-1069.
11. Lown K.S., Mayo R.R., Leichtman A.B., Hsiao H.L., Turgeon D.K., Schmiedlin-Ren P., Brown M.B., Guo W., Rossi S.J., Benet L.Z., Watkins P.B. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 62:1997;248-260.
12. Hashida T., Masuda S., Uemoto S., Saito H., Tanaka K., Inui K. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin. Pharmacol. Ther. 69:2001;308-316.
13. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P- glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3473-3478.
14. Kim R.B., Leake B.F., Choo E.F., Dresser G.K., Kubba S.V., Schwarz U.I., Taylor A., Xie H.G., McKinsey J., Zhou S., Lan L.B., Schuetz J.D., Schuetz E.G., Wilkinson G.R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 70:2001;189-199.
15. Sakaeda T., Nakamura T., Horinouchi M., Kakumoto M., Ohmoto N., Sakai T., Morita Y., Tamura T., Aoyama N., Hirai M., Kasuga M., Okumura K. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm. Res. 18:2001;1400-1404.
16. Ameyaw M.M., Regateiro F., Li T., Liu X., Tariq M., Mobarek A., Thornton N., Folayan G.O., Indalo A., Ofori-Adjei D., Price-Evans D.A., McLeod H.L. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics. 11:2001;217-221.
17. Cascorbi I., Gerloff T., Johne A., Meisel C., Hoffmeyer S., Schwab M., Schaeffeler E., Eichelbaum M., Brinkmann U., Roots I. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther. 69:2001;169-174.
18. Tanabe M., Ieiri I., Nagata N., Inoue K., Ito S., Kanamori Y., Takahashi M., Kurata Y., Kigawa J., Higuchi S., Terakawa N., Otsubo K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther. 297:2001;1137-1143.
19. Kioka N., Tsubota J., Kakehi Y., Komano T., Gottesman M.M., Pastan I., Ueda K. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 162:1989;224-231.
20. Kimchi-Sarfaty C., Gribar J.J., Gottesman M.M. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol. Pharmacol. 62:2002;1-6.
21. Kurata Y., Ieiri I., Kimura M., Morita T., Irie S., Urae A., Ohdo S., Ohtani H., Sawada Y., Higuchi S., Otsubo K. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin. Pharmacol. Ther. 72:2002;209-219.
22. Tang K., Ngoi S.M., Gwee P.C., Chua J.M., Lee E.J., Chong S.S., Lee C.G. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug tansporter gene locus in three ethnic Asian populations. Pharmacogenetics. 12(6):2002;437-450.
23. Chowbay B., Cumaraswamy S., Cheung Y.B., Zhou Q., Lee E.J. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics. 13(2):2003;89-95.
24. Johne A., Kopke K., Greloff T., Mai I., Rietbrock S., Meisel C., Hoffmeyer S., Kreb R., Fromm M.F., Brinkmann U., Eichelbaum M., Brockmoller J., Cascorbi I., Roots I. Modulation of steady state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin. Pharmacol. Ther. 72:2002;584-594.
25. O'Gorman S., Fox D.T., Wahl G.M. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science. 251:1991;1351-1355.
26. Koch K.S., Aoki T., Wang Y., Atkinson A.E., Gleiberman A.S., Glebov O.K., Leffert H.L. Site-specific integration of targeted DNA into animal cell genomes. Gene. 249:2000;135-144.
27. Tanigawara Y., Okamura N., Hirai M., Yasuhara M., Ueda K., Kioka N., Komano T., Hori R. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J. Pharmacol. Exp. Ther. 263:1992;840-845.
28. Turner R.J., Moran A. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies. Am. J. Physiol. 242:1982;F406-F414.
29. Chen C.J., Clark D., Ueda K., Pastan I., Gottesman M.M., Roninson I.B. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J. Biol. Chem. 265:1990;506-514.
30. Nakamura T., Sakaeda T., Horinouchi M., Tamura T., Aoyama N., Shirakawa T., Matsuo M., Kasuga M., Okumura K. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther. 71:2002;297-303.
31. Drescher S., Schaeffeler E., Hitzl M., Hofmann U., Schwab M., Brinkmann U., Eichelbaum M., Fromm M.F. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmacol. 53:2002;526-534.
32. Tanaka K., Hirai M., Tanigawara Y., Ueda K., Takano M., Hori R., Inui K. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene. Biochem. Pharmacol. 53:1997;741-746.
33. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267(34):1992;24248-24252.
34. Goh L.B., Spears K.J., Yao D., Ayrton A., Morgan P., Roland Wolf C., Friedberg T. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Biochem. Pharmacol. 64(11):2002;1569-1578.
35. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethazone, digoxin and cyclosporin A. J. Clin. Invest. 96:1995;1698-1705.
36. Muth T.R., Gottardi C.J., Roush D.L., Caplan M.J. A basolateral sorting signal is encoded in the α-subunit of Na-K ATPase. Am. J. Physiol. 274:1998;C688-C696.
37. Tirona R.G., Leake B.F., Merino G., Kim R.B. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J. Biol. Chem. 276:2001;35669-35675.
38. Leabman M.K., Huang C.C., Kawamoto M., Johns S.J., Stryke D., Ferrin T.E., DeYoung J., Taylor T., Clark A.G., Herskowitz I., Giacomini K.M. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics. 12:2002;395-405.
39. Keitel V., Kartenbeck J., Nies A.T., Spring H., Brom M., Keppler D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology. 32:2000;1317-1328.
40. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276:2001;14581-14587.
41. Perloff M.D., von Moltke L.L., Stormer E., Shader R.I., Greenblatt D.J. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br. J. Pharmacol. 134:2001;1601-1608.